SCHEMBL14000183

SCHEMBL14000183

Cc1ccc(N(CC(=O)Nc2ccc(-c3cocn3)cc2)C(=O)C2CCC(F)(F)CC2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ MAPT P10636 7/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ HTT P42858 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14000172 0.89 GAA (0.37) LMNAL3MBTL1GAAKMT2AMEN1
SCHEMBL14000182 0.89 KMT2A (0.37) LMNAL3MBTL1GAAKMT2AMEN1
SCHEMBL14000181 0.88 CNR1 (0.37) LMNAL3MBTL1GAAKMT2AMEN1
SCHEMBL14000185 0.88 TSHR (0.39) LMNAL3MBTL1GAAKMT2AMEN1
SCHEMBL17923456 0.88 KMT2A (0.37) LMNAL3MBTL1GAAKMT2AMEN1
SCHEMBL14000186 0.87 GAA (0.36) LMNAL3MBTL1GAAKMT2AMEN1
SCHEMBL2236768 0.87 GAA (0.36) LMNAL3MBTL1GAAKMT2AMEN1
SCHEMBL14000184 0.86 LMNA (0.36) LMNAL3MBTL1GAAKMT2AMEN1
SCHEMBL14000173 0.86 GAA (0.35) LMNAL3MBTL1GAAKMT2AMEN1
SCHEMBL14000167 0.85 RORC (0.36) LMNAL3MBTL1GAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465748-B2 Antiherpesvirus drugs; great pharmacokinetics, good antivirus activity when administered orally at a low dose, high safety profile, less mutagenic concerns; N-(2,6-dimethylphenyl)-N-(2-{[4-(1,3-oxazol-4-yl)phenyl]amino)-2-oxoethyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-dioxide ASTELLAS PHARMA INC. (JP) 2008-12-16 — — US disclosed
US-7465748-B2 Antiherpesvirus drugs; great pharmacokinetics, good antivirus activity when administered orally at a low dose, high safety profile, less mutagenic concerns; N-(2,6-dimethylphenyl)-N-(2-{[4-(1,3-oxazol-4-yl)phenyl]amino)-2-oxoethyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-dioxide ASTELLAS PHARMA INC. (JP) 2008-12-16 — — US disclosed
Send feedback